Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report-Reference-Cited by-同舟云学术

Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report

Published:2020-02 Issue: Volume:91 Page:202-205
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Hakim Aaron,Braun Hannan^ORCID,Thornton David,Strymish Judith

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference19 articles.

1. Dalvance (dalbavancin) [package insert];Allergan,2019

2. Dalbavancin use for the treatment of methicillin-resistant Staphylococcus aureus pneumonia;Barber;J Pharmacol Pharmacother,2017

3. Dalbavancin as secondary therapy for serious Staphylococcus aureus infections in a vulnerable patient population;Bryson-Cahn;Open Forum Infect Dis,2019

4. French national cohort of first use of dalbavancin: a high proportion of off-label use;Dinh;Int J Antimicrob Agents,2019

5. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections;Fernandez;Diagn Microbiol Infect Dis,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMPs as Host-Directed Immunomodulatory Agents against Skin Infections Caused by Opportunistic Bacterial Pathogens;Antibiotics;2024-05-13

2. A Promising Approach to Addressing the Needs of Patients with Endocarditis Secondary to Injection Drug Use: A Case Report;Health & Social Work;2023-12-20

3. New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended;Journal of Clinical Medicine;2023-12-14

4. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02

5. Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review;International Journal of Antimicrobial Agents;2023-04